コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 effective in discriminating both groups from frontotemporal lobar degeneration.
2 l forms of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
3 ures through which TMEM106B confers risk for frontotemporal lobar degeneration.
4 ination of amnestic Alzheimer's disease from frontotemporal lobar degeneration.
5 e diseases amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
6 otrophic lateral sclerosis and some types of frontotemporal lobar degeneration.
7 iverse clinical syndromes, all attributed to frontotemporal lobar degeneration.
8 e disorders, including Parkinson disease and frontotemporal lobar degeneration.
9 lusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
10 esicular body protein 2B (CHMP2B) gene cause frontotemporal lobar degeneration.
11 these disorders and other clinical forms of frontotemporal lobar degeneration.
12 ase and some forms of non-amyloid-associated frontotemporal lobar degeneration.
13 1S human tau mutation, which causes familial frontotemporal lobar degeneration.
14 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
15 es such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
16 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
17 s prediction of histopathological subtype of frontotemporal lobar degeneration.
18 ple of patients with pathologically verified frontotemporal lobar degeneration.
19 as initially identified as a risk factor for frontotemporal lobar degeneration.
20 Alzheimer's disease, Lewy body disease, and frontotemporal lobar degeneration.
21 established criteria in a sample with known frontotemporal lobar degeneration.
22 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
23 ogranulin gene are a major cause of familial frontotemporal lobar degeneration.
24 cellular apoptosis susceptibility protein in frontotemporal lobar degeneration.
25 e in the pathogenesis of the TDP-43 positive frontotemporal lobar degeneration.
26 e considered a separate syndromic variant of frontotemporal lobar degeneration.
27 s now considered one of the main variants of frontotemporal lobar degeneration.
28 n patients suffering from AD from those with frontotemporal lobar degeneration.
29 s the latest developments in the genetics of frontotemporal lobar degeneration.
30 with MAPT mutations), and three had non-tau frontotemporal lobar degeneration.
31 D), progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration.
32 ically diagnosed or autopsy-confirmed AD and frontotemporal lobar degeneration.
33 us and risk of the neurodegenerative disease frontotemporal lobar degeneration.
34 hic lateral sclerosis and ubiquitin-positive frontotemporal lobar degeneration.
35 o differentiate and track different types of frontotemporal lobar degeneration.
36 ity are common and disabling consequences of frontotemporal lobar degeneration.
37 ne were identified in patients with familial Frontotemporal Lobar Degeneration.
38 thogenesis amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
39 tive disorders in addition to ALS, including frontotemporal lobar degeneration.
41 nd a substantial proportion of patients with frontotemporal lobar degeneration (~45%) exhibit TDP-43
43 f-function mutations in the PGRN gene causes frontotemporal lobar degeneration accompanied by TDP-43
44 nded repeat carriers were also identified in frontotemporal lobar degeneration, Alzheimer's and Parki
45 veral neurodegenerative disorders, including frontotemporal lobar degeneration, amyotrophic lateral s
46 ration, 50 with Alzheimer's disease, 19 with frontotemporal lobar degeneration and 54 healthy individ
47 cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnos
48 ATE shares pathogenetic mechanisms with both frontotemporal lobar degeneration and Alzheimer's diseas
49 cribed as a significant risk factor for both frontotemporal lobar degeneration and Alzheimer's diseas
50 e protein aggregates in distinct subtypes of frontotemporal lobar degeneration and amyotrophic latera
51 form the diagnostic signature inclusions of frontotemporal lobar degeneration and amyotrophic latera
52 d array of TDP-43 proteinopathies, including frontotemporal lobar degeneration and amyotrophic latera
54 with neurodegenerative diseases, especially frontotemporal lobar degeneration and amyotrophic latera
55 to the differentiation between syndromes of frontotemporal lobar degeneration and focal forms of Alz
56 co-registered magnetic resonance imaging in frontotemporal lobar degeneration and imaging of nigrost
57 siology of amyotrophic lateral sclerosis and frontotemporal lobar degeneration and is essential for e
58 been identified as a major cause of familial frontotemporal lobar degeneration and motor neuron disea
60 dementia with Lewy bodies, 55 patients with frontotemporal lobar degeneration), and scans from 73 he
61 ases, such as amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer's disea
62 tissue samples from pathologically confirmed frontotemporal lobar degeneration, and in silico techniq
63 ive diseases, including Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disea
64 n samples from patients with TDP-43 positive frontotemporal lobar degeneration, and spinal cord sampl
65 ies including amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and sporadic inclusio
66 ATN framework was relatively insensitive to frontotemporal lobar degeneration, and these patients we
67 th risk of neurodegenerative diseases beyond frontotemporal lobar degeneration are enriched in CTCF-b
70 iate filament inclusion disease and atypical frontotemporal lobar degeneration are rare diseases char
71 er the curve of 0.894) and autopsy-confirmed frontotemporal lobar degeneration (area under the curve
72 ion to other forms of genetically determined frontotemporal lobar degeneration ascertained at a speci
73 lin (GRN) is a major genetic risk factor for frontotemporal lobar degeneration associated with TDP-43
74 ons in two TDP-43 proteinopathies, including frontotemporal lobar degeneration associated with TDP-43
76 6B rs1990622 polymorphism is associated with frontotemporal lobar degeneration, but little is known a
77 erative disorders, including the majority of frontotemporal lobar degeneration cases (FTLD-TDP), moto
78 total) were identified, representing 35% of frontotemporal lobar degeneration cases with identified
80 g protein TDP-43 in neurons is a hallmark of frontotemporal lobar degeneration caused by haploinsuffi
81 ologically ascertained cohort of 95 cases of frontotemporal lobar degeneration classified according t
83 ean diffusivity correlated with the modified frontotemporal lobar degeneration clinical dementia rati
84 ormed correlation analyses with the modified frontotemporal lobar degeneration clinical dementia rati
85 ng the Mini-Mental State Examination (MMSE), Frontotemporal Lobar Degeneration-Clinical Dementia Rati
86 grey matter regions, but not with change in Frontotemporal Lobar Degeneration-Clinical Dementia Rati
87 the voxel-based morphometry analysis of the frontotemporal lobar degeneration cohort, pain and tempe
88 nating non-amnestic Alzheimer's disease from frontotemporal lobar degeneration, compared to discrimin
90 inical importance of the C9ORF72 mutation in frontotemporal lobar degeneration, delineate phenotypic
92 results show that syndromes associated with frontotemporal lobar degeneration do not form discrete m
93 t, we observed that alpha-synucleinopathies, frontotemporal lobar degeneration due to tau and TAR DNA
94 tive disease diagnosis (Alzheimer's disease, frontotemporal lobar degeneration due to tau, and TAR DN
96 s in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, followed by the disco
98 nation [MMSE] score +/- SD, 22.2 +/- 6.0) or frontotemporal lobar degeneration (FTLD) (n = 31; age +/
100 s correlate with postmortem tau pathology in frontotemporal lobar degeneration (FTLD) and (2) tauopat
101 any neurodegenerative pathologies, including frontotemporal lobar degeneration (FTLD) and amyotrophic
102 at expansion in C9orf72 is a common cause of frontotemporal lobar degeneration (FTLD) and amyotrophic
103 ficant heterogeneity in clinical features of frontotemporal lobar degeneration (FTLD) and amyotrophic
104 t expansions in C9orf72 are a major cause of frontotemporal lobar degeneration (FTLD) and amyotrophic
105 nding protein that forms inclusion bodies in frontotemporal lobar degeneration (FTLD) and amyotrophic
107 e (GRN) is mutated in 5-10% of patients with frontotemporal lobar degeneration (FTLD) and in about 20
108 rogranulin (PGRN) gene (GRN) causes familial frontotemporal lobar degeneration (FTLD) and modulates a
109 gical syndromes: haploinsufficiency leads to frontotemporal lobar degeneration (FTLD) and nullizygosi
110 Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characteriz
111 Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are neurodegene
113 lusions of amyotrophic lateral sclerosis and frontotemporal lobar degeneration (FTLD) characterized b
115 ospinal fluid (CSF) has been associated with frontotemporal lobar degeneration (FTLD) in clinical ser
116 oses included Alzheimer's disease in 45% and frontotemporal lobar degeneration (FTLD) in the others,
124 neuropathologic entities, including forms of frontotemporal lobar degeneration (FTLD) or Alzheimer di
125 (AD) pathology (n=21) and those with likely frontotemporal lobar degeneration (FTLD) pathology (n=45
127 re reviewed that help identify patients with frontotemporal lobar degeneration (FTLD) spectrum abnorm
128 isease (AD), although sensitive detection of frontotemporal lobar degeneration (FTLD) tau inclusions
129 h elderly control subjects and patients with frontotemporal lobar degeneration (FTLD) to determine wh
131 aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DN
132 actor in a genome-wide association study for frontotemporal lobar degeneration (FTLD) with TAR DNA-bi
133 l FTD cases are classified pathologically as frontotemporal lobar degeneration (FTLD) with TAR DNA-bi
134 uopathies, include Alzheimer's disease (AD), frontotemporal lobar degeneration (FTLD) with tau pathol
135 ), progressive supranuclear palsy (13%), and frontotemporal lobar degeneration (FTLD) with TDP inclus
136 linical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactiv
137 ranulin gene (GRN) are an important cause of frontotemporal lobar degeneration (FTLD) with ubiquitin
138 rise amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with ubiquitin
139 c of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with ubiquitin-
140 age 63, neuropathologic examination revealed frontotemporal lobar degeneration (FTLD) with ubiquitin-
141 d in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with ubiquitina
142 98 with a primary pathological diagnosis of frontotemporal lobar degeneration (FTLD), 15 with Alzhei
144 utations in the progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD), a progressive
145 fulfilling clinical diagnostic criteria for frontotemporal lobar degeneration (FTLD), and 259 patien
146 er's disease (AD), Parkinson's disease (PD), frontotemporal lobar degeneration (FTLD), and amyotrophi
147 mutations in the granulin (GRN) gene causes frontotemporal lobar degeneration (FTLD), and complete l
148 Severe empathy loss is a common feature of frontotemporal lobar degeneration (FTLD), and is also se
149 d to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), but it is not
150 ic ALS, ALS mimics (disease controls (DCo)), frontotemporal lobar degeneration (FTLD), Creutzfeldt-Ja
151 ral sclerosis (ALS) and approximately 50% of frontotemporal lobar degeneration (FTLD), designated as
152 tive dementias, Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD), has greatly ad
153 pathology of frontotemporal dementia, termed frontotemporal lobar degeneration (FTLD), is characteriz
155 llele causes haploinsufficiency and leads to frontotemporal lobar degeneration (FTLD), the second lea
156 ost common clinical syndrome associated with frontotemporal lobar degeneration (FTLD)--and several pr
157 inclusions in TDP-43 proteinopathies such as frontotemporal lobar degeneration (FTLD)-TDP are made of
180 icantly increased in brains of patients with frontotemporal lobar degeneration (FTLD-tau), a disease
181 veral neurodegenerative disorders, including frontotemporal lobar degeneration (FTLD-TDP) and amyotro
182 Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP) are two neu
189 ment was more severe in the temporal variant frontotemporal lobar degeneration group than the Alzheim
191 atients with semantic dementia, a variant of frontotemporal lobar degeneration, has emerged over the
195 y cause disease in patients with a subset of frontotemporal lobar degeneration; however, the biologic
196 made in our understanding of the genetics of frontotemporal lobar degeneration in recent years, the m
197 ients with a syndrome likely to be caused by frontotemporal lobar degeneration, including behavioural
198 racteristic of human Alzheimer's disease and frontotemporal lobar degeneration, including beta-amyloi
199 ose humans to amyotrophic lateral sclerosis, frontotemporal lobar degeneration, inclusion body myopat
200 he spectrum of pathological changes found in frontotemporal lobar degeneration involving the microtub
207 ders, including Alzheimer's disease (AD) and frontotemporal lobar degeneration, is associated with di
208 d to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, is important for the
210 ase at the mild stage (N = 16 patients) from frontotemporal lobar degeneration (N = 11 patients) and
211 nonical dementia syndromes: temporal variant frontotemporal lobar degeneration (n = 14) and Alzheimer
212 or temperature for a cohort of patients with frontotemporal lobar degeneration (n = 58, 25 female, ag
213 nalysis of the 7p21 locus linked by GWASs to frontotemporal lobar degeneration, nominating a causal v
214 s of frontal lobe dysfunction resulting from frontotemporal lobar degeneration or Alzheimer's disease
216 he neuroanatomical specificity of particular frontotemporal lobar degeneration pathologies may depend
217 Subtyping PPA helps to predict AD versus frontotemporal lobar degeneration pathology at the group
218 tients (98 amnestic; 20 non-amnestic) and 64 frontotemporal lobar degeneration patients (five amnesti
219 opathies, which include Alzheimer's disease, frontotemporal lobar degeneration, Pick's disease, progr
220 relative paucity of information relating to frontotemporal lobar degeneration primarily affecting th
221 to complex behavioural changes arising from frontotemporal lobar degeneration provides new insights
222 riant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopatholo
223 Here we report that the recently identified frontotemporal lobar degeneration risk factor TMEM106B u
224 and may shed light on the regulation of the frontotemporal lobar degeneration risk factor TMEM106B.
225 in six cases with C9ORF72 mutation from the frontotemporal lobar degeneration series identified hist
226 s with non-Alzheimer tauopathies and non-tau frontotemporal lobar degeneration showed a range of trac
228 to clinical phenotypes, particularly in the frontotemporal lobar degeneration spectrum, but the basi
230 c forms of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, suggesting that eithe
231 transdiagnostic approach to the spectrum of frontotemporal lobar degeneration syndromes provides a u
233 distinct from previously published cases of frontotemporal lobar degeneration TAR DNA protein 43.
234 otein-43 deposition in 53 control cases with frontotemporal lobar degeneration-TAR DNA-binding protei
235 pathological diagnosis of Alzheimer disease, frontotemporal lobar degeneration-tau, frontotemporal lo
237 amilial neurodegenerative disorder, known as frontotemporal lobar degeneration tauopathy (FTLD-Tau),
239 linical diagnoses of one of the syndromes of frontotemporal lobar degeneration, the high proportion r
240 h groups of pathologies from the spectrum of frontotemporal lobar degeneration: the most frequent wer
241 t-mortem confirmed diagnosis of either AD or frontotemporal lobar degeneration to their respective gr
242 ease, frontotemporal lobar degeneration-tau, frontotemporal lobar degeneration-transactive response D
244 r spinal cords from 22 cases with or without frontotemporal lobar degeneration were also studied.
245 but particularly severe in temporal variant frontotemporal lobar degeneration, whereas impairments o
246 PGRN) underlie the neurodegenerative disease frontotemporal lobar degeneration, while homozygous loss
247 included in investigations of patients with frontotemporal lobar degenerations who show unusual whit
248 cases and two cases of ALS plus concomitant frontotemporal lobar degeneration with a remarkable conc
249 ation mechanisms might instead be related to frontotemporal lobar degeneration with abnormal TARDBP.
250 egeneration, argyrophilic grain disease, and frontotemporal lobar degeneration with MAPT mutations),
251 ntic scores across a set of 21 patients with frontotemporal lobar degeneration with semantic impairme
252 that, when deficient, is linked to cases of frontotemporal lobar degeneration with TAR DNA-binding p
253 tau astrogliopathy and multiple subtypes of frontotemporal lobar degeneration with tau inclusions.
254 hies, including Alzheimer's disease (AD) and frontotemporal lobar degeneration with tau pathologies,
255 assification issues among LATE-NC, ADNC, and frontotemporal lobar degeneration with TDP-43 (FTLD-TDP)
257 aracterize amyotrophic lateral sclerosis and frontotemporal lobar degeneration with TDP-43 inclusions
258 ressive aphasia and, at autopsy, showed both frontotemporal lobar degeneration with TDP-43 inclusions
261 esulting in protein haploinsufficiency cause frontotemporal lobar degeneration with TDP-43 inclusions
262 06B variants are genetically associated with frontotemporal lobar degeneration with TDP-43 pathology
263 postmortem human brain tissue afflicted with frontotemporal lobar degeneration with TDP-43 pathology
265 ents with amyotrophic lateral sclerosis, and frontotemporal lobar degeneration with TDP-43 positive u
266 with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43(+) inclusi
267 sclerosis (ALS) and frontotemporal dementia-frontotemporal lobar degeneration with TDP-43-positive i
268 hological subtype of frontotemporal dementia-frontotemporal lobar degeneration with TDP-43-positive i
270 at there exists a unique association between frontotemporal lobar degeneration with type C pathology
271 a secreted glycoprotein, is a major cause of frontotemporal lobar degeneration with ubiquitin (FTLD-U
272 rtial loss of the encoded PGRN protein cause frontotemporal lobar degeneration with ubiquitin immunor
274 n (PGRN) cause the neurodegenerative disease frontotemporal lobar degeneration with ubiquitin inclusi
275 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin positiv
276 Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin positiv
277 bodies (DLB), mixed Alzheimer's disease/DLB, frontotemporal lobar degeneration with ubiquitin-only-im
278 luding: amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration with ubiquitin-positiv
279 pal component of ubiquitinated inclusions in frontotemporal lobar degeneration with ubiquitin-positiv
280 including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positiv
282 ied as the pathological signature protein in frontotemporal lobar degeneration with ubiquitin-positiv
283 is (ALS), a fatal motor neuron disorder, and frontotemporal lobar degeneration with ubiquitin-positiv
284 re the defining histopathological feature of frontotemporal lobar degeneration with ubiquitin-positiv
285 rotein 43 (TDP-43) is the disease protein in frontotemporal lobar degeneration with ubiquitin-positiv
286 progranulin gene (GRN) are a major cause of frontotemporal lobar degeneration with ubiquitin-positiv
287 ubstrate of neuronal and glial inclusions in frontotemporal lobar degeneration with ubiquitin-positiv
288 athological protein of sporadic and familial frontotemporal lobar degeneration with ubiquitin-positiv
289 nuclein-negative inclusions are hallmarks of frontotemporal lobar degeneration with ubiquitin-positiv
290 opathologically, HDDD2 represents a familial frontotemporal lobar degeneration with ubiquitin-positiv
292 opathy in the nonfluent cases (10 of 23) and frontotemporal lobar degeneration with ubiquitin-positiv
293 s of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positiv
294 d shown to be more insoluble in the atypical frontotemporal lobar degeneration with ubiquitinated inc
295 iate filament inclusion disease and atypical frontotemporal lobar degeneration with ubiquitinated inc
297 ll as the caudate in the cases with atypical frontotemporal lobar degeneration with ubiquitinated inc
298 k of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitinated inc
299 present in the hallmark inclusion bodies of frontotemporal lobar degeneration with ubiquitinated inc
300 is study aimed to determine the frequency of frontotemporal lobar degeneration with ubiquitinated inc